The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression

Biomed Pharmacother. 2021 May:137:111389. doi: 10.1016/j.biopha.2021.111389. Epub 2021 Feb 15.

Abstract

As a type of non-coding RNA of more than 200 nucleotides, long non-coding RNAs(lncRNAs) lack protein coding ability and can regulate gene expression. MicroRNAs(miRNAs), which are also non-coding RNAs, are short single-stranded RNAs, usually composed of 18-23 nucleotides. MiRNAs inhibits gene expression by specifically binding to the 3'-UTR of downstream target mRNAs and can function as oncogenes or suppressor oncogenes to regulate the occurrence and development of cancer. LncRNAs can function as competitive endogenous RNAs that bind to miRNAs, resulting in the recovery of downstream mRNA expression and activity. The regulatory network existing between lncRNAs, miRNAs and mRNAs regulates a variety of biological processes, including cell proliferation, apoptosis, migration and invasion as well as cell-cycle arrest. Disruption of the ceRNA network affects cell growth and development and often leads to various diseases, especially cancer. The lncRNA MALAT1, which is located on chromosome 11q13, contains more than 8000 nucleotides and is implicated in the occurrence and development of many cancers. Here, we review the impact of the ceRNA network and the lncRNA MALAT1 in cancer.

Keywords: Cancer; MALAT1; ceRNA; lncRNA; miRNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Metabolic Networks and Pathways / genetics*
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • RNA / genetics*
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • MALAT1 long non-coding RNA, human
  • RNA, Long Noncoding
  • RNA